Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Cook IVC Filter Study [NA]
Clinical trial update for the Cook IVC Filter study (NCT02046096) indicates completion and results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE [Phase 3]
Phase 3 trial comparing catheter-directed thrombolysis to anticoagulation monotherapy in intermediate-high risk pulmonary embolism was termi…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Screening for Cancer in Patients With Unprovoked VTE [Phase 4]
Phase 4 trial update focused on screening for cancer in patients with unprovoked venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Chemoprophylaxis Plus Early Ambulation [Phase 4]
A Phase 4 clinical trial update on chemoprophylaxis plus early ambulation for patients with pulmonary embolism and thoracic surgery has comp…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism [Phase 4]
Phase 4 trial evaluating low-dose tenecteplase for patients with pulmonary embolism diagnosed with COVID-19; study terminated with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-10-08Clinical Trial Update: Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study [Phase 4]
A Phase 4 randomized trial evaluating enoxaparin versus placebo for preventing venous thromboembolism in low-risk cancer patients after surg…
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Breath Analysis Technique to Diagnose Pulmonary Embolism [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating a breath analysis technique for diagnosing pulmonary embolism has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism [Phase 4]
Phase 4 trial update on standard-dose apixaban after very low-dose thrombolysis for acute intermediate-high risk acute pulmonary embolism; t…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: FlowTriever Pulmonary Embolectomy Clinical Study [NA]
Clinical trial update for the FlowTriever Pulmonary Embolectomy study (NCT02692586) completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism [Phase 2]
A Phase 2 clinical trial evaluating low-dose catheter-directed thrombolysis for acute pulmonary embolism is reported, with status currently …
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism [Phase 4]
Phase 4 clinical trial updating D-dimer guidance to establish duration of anticoagulation after venous thromboembolism has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism [Phase 2]
Phase 2 trial update for recombinant human prourokinase in acute pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism [Phase 4]
Phase 4 trial update for the optimum duration of acoustic pulse thrombolysis in acute pulmonary embolism; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients
A completed clinical trial evaluating identification of chronic thromboembolic pulmonary hypertension (CTEPH) using standard computerized to…
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
FDA approved the original ANDA for Heparin Sodium from BE Pharmaceuticals Inc., providing a generic version of heparin for anticoagulation.
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
The FDA approved BE Pharmaceuticals Inc.'s original application for Heparin Sodium (a generic anticoagulant). It is used to prevent and trea…
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Thrombolysis Endovascular Treatment of Pulmonary Embolism [Phase 3]
Phase 3 trial update on thrombolysis endovascular treatment for pulmonary embolism has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: PEITHO Pulmonary Embolism Thrombolysis Study [Phase 3]
Phase 3 trial update for PEITHO study investigating thrombolysis in pulmonary embolism; status completed.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification [Phase 4]
Phase 4 trial comparing rivaroxaban to vitamin K antagonists in patients requiring long-term anticoagulation with cardiovascular calcificati…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive [Phase 4]
Phase 4 clinical trial update on diuretic vascular filling in the initial management of acute pulmonary embolism with right ventricular dysf…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery [Phase 2]
A Phase 2 clinical trial update focusing on reducing bleeding-related adverse events in patients undergoing plastic and reconstructive surge…
-
FDA approval · 2020-08-25FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
FDA approves a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Evaluating the Safety and Efficacy of the Indigo® Aspiration System in Acute Pulmonary Embolism [NA]
Clinical trial update on the Indigo Aspiration System for acute pulmonary embolism; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and pharmacokinetics/dynamics of DS-1040b in subjects with acute submassive pulmonary embolism has complete…
-
FDA approval · 2020-07-15FDA Approved: HEPARIN SODIUM — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' generic heparin sodium (Original Application) as an injectable anticoagulant. It covers the same indi…